DuPont Guerry

9.2k total citations · 1 hit paper
140 papers, 6.4k citations indexed

About

DuPont Guerry is a scholar working on Oncology, Ophthalmology and Molecular Biology. According to data from OpenAlex, DuPont Guerry has authored 140 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Oncology, 36 papers in Ophthalmology and 30 papers in Molecular Biology. Recurrent topics in DuPont Guerry's work include Cutaneous Melanoma Detection and Management (53 papers), Skin Protection and Aging (13 papers) and Melanoma and MAPK Pathways (12 papers). DuPont Guerry is often cited by papers focused on Cutaneous Melanoma Detection and Management (53 papers), Skin Protection and Aging (13 papers) and Melanoma and MAPK Pathways (12 papers). DuPont Guerry collaborates with scholars based in United States, Australia and Canada. DuPont Guerry's co-authors include David E. Elder, Wallace H. Clark, Mark H. Greene, Phyllis A. Gimotty, Allan C. Halpern, Harold A. Mueller, Martin N. Epstein, John J. Ruffolo, William T. Ham and Walter J. Geeraets and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

DuPont Guerry

130 papers receiving 5.8k citations

Hit Papers

A study of tumor progression: The precursor lesions of su... 1984 2026 1998 2012 1984 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DuPont Guerry United States 44 3.4k 2.0k 1.2k 1.1k 916 140 6.4k
Lynn From Canada 31 3.3k 1.0× 1.4k 0.7× 1.3k 1.1× 154 0.1× 763 0.8× 82 4.7k
Michael W. Piepkorn United States 38 3.3k 1.0× 1.9k 0.9× 907 0.8× 138 0.1× 888 1.0× 142 5.6k
Alfred W. Kopf United States 60 7.6k 2.2× 2.2k 1.1× 4.2k 3.5× 329 0.3× 3.7k 4.0× 283 11.1k
Robert S. Bart United States 38 3.6k 1.0× 1.2k 0.6× 2.2k 1.8× 207 0.2× 1.9k 2.0× 138 5.5k
Daniel M. Albert United States 53 4.1k 1.2× 4.9k 2.5× 1.1k 0.9× 7.5k 6.8× 1.8k 2.0× 482 15.1k
Robert Folberg United States 46 2.4k 0.7× 3.8k 1.9× 318 0.3× 4.2k 3.9× 482 0.5× 191 8.8k
Hensin Tsao United States 50 5.5k 1.6× 5.1k 2.6× 1.4k 1.2× 270 0.2× 1.1k 1.2× 191 9.6k
Stefania Staibano Italy 43 2.4k 0.7× 2.8k 1.4× 646 0.5× 162 0.1× 725 0.8× 229 6.5k
Paul Nathan United Kingdom 46 3.8k 1.1× 3.6k 1.8× 242 0.2× 573 0.5× 524 0.6× 272 7.9k
Reidar Grénman Finland 64 5.0k 1.5× 5.4k 2.7× 336 0.3× 317 0.3× 770 0.8× 356 13.7k

Countries citing papers authored by DuPont Guerry

Since Specialization
Citations

This map shows the geographic impact of DuPont Guerry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DuPont Guerry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DuPont Guerry more than expected).

Fields of papers citing papers by DuPont Guerry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DuPont Guerry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DuPont Guerry. The network helps show where DuPont Guerry may publish in the future.

Co-authorship network of co-authors of DuPont Guerry

This figure shows the co-authorship network connecting the top 25 collaborators of DuPont Guerry. A scholar is included among the top collaborators of DuPont Guerry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DuPont Guerry. DuPont Guerry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guerry, DuPont, et al.. (2024). Oncology: What You May Have Missed in 2023. Annals of Internal Medicine. 177(5_Supplement). S57–S70.
2.
Xu, Xiaowei, Phyllis A. Gimotty, DuPont Guerry, Giorgos C. Karakousis, & David E. Elder. (2013). Lymphatic Invasion as a Prognostic Biomarker in Primary Cutaneous Melanoma. Methods in molecular biology. 1102. 275–286. 16 indexed citations
3.
Levy, Ross M., Michael E. Ming, Michael B. Shapiro, et al.. (2007). Eruptive disseminated Spitz nevi. Journal of the American Academy of Dermatology. 57(3). 519–523. 24 indexed citations
4.
Elder, David E., Phyllis A. Gimotty, & DuPont Guerry. (2005). Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic features. Dermatologic Therapy. 18(5). 369–385. 30 indexed citations
5.
Li, Jian, Weiping Li, Shaohong Liang, et al.. (2003). Recombinant CD63/ME491/Neuroglandular/NKI/C-3 Antigen Inhibits Growth of Established Tumors in Transgenic Mice. The Journal of Immunology. 171(6). 2922–2929. 3 indexed citations
6.
Blackwood, M. Anne, Robin Holmes, Marie Synnestvedt, et al.. (2002). Multiple primary melanoma revisited. Cancer. 94(8). 2248–2255. 53 indexed citations
7.
Kanetsky, Peter A., et al.. (2002). A Polymorphism in the Agouti Signaling Protein Gene Is Associated with Human Pigmentation. The American Journal of Human Genetics. 70(3). 770–775. 143 indexed citations
8.
Smith, Jason G., Yueh J. Chang, DuPont Guerry, et al.. (1998). Adenoviral transduction of melanoma cells with B7-1: antitumor immunity and immunosuppressive factors. Cancer Immunology Immunotherapy. 46(5). 283–292. 18 indexed citations
9.
Halpern, Allan C., Lynn M. Schuchter, David E. Elder, et al.. (1994). Effects of topical tretinoin on dysplastic nevi.. Journal of Clinical Oncology. 12(5). 1028–1035. 29 indexed citations
10.
Tucker, Margaret A., et al.. (1993). Risk of Melanoma and Other Cancers in Melanoma-Prone Families.. Journal of Investigative Dermatology. 100(3). 350S–355S. 90 indexed citations
11.
Guerry, DuPont, Marie Synnestvedt, David E. Elder, & Delray Schultz. (1993). Lessons from Tumor Progression: The Invasive Radial Growth Phase of Melanoma Is Common, Incapable of Metastasis, and Indolent.. Journal of Investigative Dermatology. 100(3). 342S–345S. 12 indexed citations
12.
Clark, Wallace H., et al.. (1990). Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. Journal of the American Academy of Dermatology. 22(6). 1042–1048. 153 indexed citations
13.
Cassileth, Barrie R., Lydia Temoshok, William P. Walsh, et al.. (1988). Patient and physician delay in melanoma diagnosis. Journal of the American Academy of Dermatology. 18(3). 591–598. 49 indexed citations
14.
Guerry, DuPont. (1970). Symposium on Ocular Therapy. American Journal of Ophthalmology. 70(2). 302–302. 2 indexed citations
15.
Geeraets, Walter J., et al.. (1967). Traumatic Hyphema: A Review of Experience at the Medical College of Virginia During the Past Decade. VCU Scholars Compass (Virginia Commonwealth University). 3(1). 20–25. 5 indexed citations
16.
Guerry, DuPont. (1966). Observations on Cogan's Microcystis Dystrophy of the Corneal Epithelium. American Journal of Ophthalmology. 62(1). 65–73. 32 indexed citations
17.
Guerry, DuPont & Herbert Wiesinger. (1960). Light Coagulation. American Journal of Ophthalmology. 49(1). 87–96. 4 indexed citations
18.
Wiesinger, Herbert, DuPont Guerry, & Walter J. Geeraets. (1960). Recent Experiences with Light Coagulation. Archives of Ophthalmology. 64(2). 254–259. 7 indexed citations
19.
Guerry, DuPont & Herbert Wiesinger. (1957). Spontaneous Cyst of the Iris Stroma. American Journal of Ophthalmology. 44(1). 106–107. 18 indexed citations
20.
Guerry, DuPont, et al.. (1954). Pyocyaneus Ulcer. American Journal of Ophthalmology. 37(4). 538–544. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026